Abstract
Nephrolithiasis is a common condition. The most common types of kidney stones contain calcium (most often calcium oxalate or calcium phosphate), representing 90 % of all stones.
The etiology of calcium nephrolithiasis is multifactorial, involving nutritional, environmental, and genetic determinants. Genetics play a role in defining the metabolic “milieu” from which kidney stones may form. Monogenic stone-forming conditions are rare but very interesting as “models” to highlight the genetic component of idiopathic nephrolithiasis. Among the others, a tendency to form stones may derive from anomalies of the calcium-sensing receptor, adenylyl cyclase, vitamin D receptor, claudin, chloride channels, phosphatidylinositol 4,5-bisphosphate 5-phosphatase, sodium/phosphate transporter, carriers involved in the pathogenesis of distal renal tubular acidosis, genes involved in renal morphogenesis, and medullary sponge kidney.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Stamatelou KK, Francis ME, Jones CA, et al. Time trends in reported prevalence of kidney stones in the united states: 1976-1994. Kidney Int. 2003;63:1817–23.
Curhan GC, Willett WC, Rimm EB, et al. Family history and risk of kidney stones. J Am Soc Nephrol. 1997;8:1568–73.
Goldfarb DS, Fischer ME, Keich Y, et al. A twin study of genetic and dietary influences on nephrolithiasis: a report from the Vietnam Era Twin (VET) registry. Kidney Int. 2005;67:1053–61.
Lerolle N, Lantz B, Paillard F, et al. Risk factors for nephrolithiasis in patients with familial idiopathic hypercalciuria. Am J Med. 2002;113:99–103.
Nicolaidou P, Themeli S, Karpathios T, et al. Family pattern of idiopathic hypercalciuria and its subtypes. J Urol. 1996;155:1042–4.
Harangi F, Méhes K. Family investigations in idiopathic hypercalciuria. Eur J Pediatr. 1993;152:64–8.
Lerolle N, Coulet F, Lantz B, Paillard F, Houillier P, Soubrier F, Gattegno B, Jeunemaitre X, Ronco P, Rondeau E. No evidence for point mutations of the calcium-sensing receptor in familial idiopathic hypercalciuria. Nephrol Dial Transplant. 2001;16:2317–22.
Loredo-Osti JC, Roslin NM, Tessier J, et al. Segregation of urine calcium excretion in families ascertained for nephrolithiasis: evidence for a major gene. Kidney Int. 2005;68:966–71.
Falchetti A, Vezzoli G, Gambaro G. Genetics of primary hypercalciuria. Clin Cases Miner Bone Metab. 2004;1:27–33.
Hunter D, De Lange M, Snieder H, et al. Genetic contribution to bone metabolism, calcium excretion, and vitamin D and parathyroid hormone regulation. J Bone Miner Res. 2001;16:371–8.
Vezzoli G, Soldati L, Gambaro G. Hypercalciuria revisited: one or many conditions? Pediatr Nephrol. 2008;23:503–6.
Aladjem M, Barr J, Lahat E, et al. Renal and absorptive hypercalciuria: a metabolic disturbance with varying and interchanging modes of expression. Pediatrics. 1996;97:216–9.
Maierhofer WJ, Lemann Jr J, Gray RW, et al. Dietary calcium and serum 1,25-(OH)2-vitamin D concentrations as determinants of calcium balance in healthy men. Kidney Int. 1984;26:752–9.
Vezzoli G, Terranegra A, Arcidiacono T, et al. R990G polymorphism of calcium-sensing receptor does produce a gain-of-function and predispose to primary hypercalciuria. Kidney Int. 2007;71:1155–62.
Hendy GN, D’Souza-Li L, Yang B, et al. Mutations of the calcium-sensing receptor (CASR) in familial hypocalciuric hypercalcemia, neonatal severe hyperparathyroidism, and autosomal dominant hypocalcemia. Hum Mutat. 2000;16:281–96.
Vargas-Poussou R, Huang C, Hulin P, et al. Functional characterization of a calcium-sensing receptor mutation in severe autosomal dominant hypocalcemia with a Bartter-like syndrome. J Am Soc Nephrol. 2002;13:2259–66.
Sands JM, Naruse M, Baum M, et al. Apical extracellular calcium/polyvalent cation-sensing receptor regulates vasopressin-elicited water permeability in rat kidney inner medullary collecting duct. J Clin Invest. 1997;99:1399–405.
Vezzoli G, Terranegra A, Arcidiacono T, et al. Calcium kidney stones are associated with a haplotype of the calcium-sensing receptor gene regulatory region. Nephrol Dial Transplant. 2010;25:2245–52.
Reed BY, Heller HJ, Gitomer WL, et al. Mapping a gene defect in absorptive hypercalciuria to chromosome 1q23.3-q24. J Clin Endocrinol Metab. 1999;84:3907–13.
Zerwekh JE, Yu XP, Breslau NA, et al. Vitamin D receptor quantitation in human blood mononuclear cells in health and disease. Mol Cell Endocrinol. 1993;96:1–6.
Scott P, Ouimet D, Valiquette L, et al. Suggestive evidence for a susceptibility gene near the vitamin D receptor locus in idiopathic calcium stone formation. J Am Soc Nephrol. 1999;10:1007–13.
Scott P, Ouimet D, Proulx Y, et al. The 1 alpha-hydroxylase locus is not linked to calcium stone formation or calciuric phenotypes in French-Canadian families. J Am Soc Nephrol. 1998;9:425–32.
Konrad M, Schaller A, Seelow D, et al. Mutations in the tight-junction gene claudin 19 (CLDN19) are associated with renal magnesium wasting, renal failure, and severe ocular involvement. Am J Hum Genet. 2006;79:949–57.
Gambaro G, Vezzoli G, Casari G, et al. Genetics of hypercalciuria and calcium nephrolithiasis: from the rare monogenic to the common polygenic forms. Am J Kidney Dis. 2004;44:963–86.
Besbas N, Ozaltin F, Jeck N, et al. CLCN5 mutation (R347X) associated with hypokalaemic metabolic alkalosis in a Turkish child: an unusual presentation of Dent’s disease. Nephrol Dial Transplant. 2005;20:1476–9.
Hoopes Jr RR, Shrimpton AE, Knohl SJ, et al. Dent disease with mutations in OCRL1. Am J Hum Genet. 2005;76:260–7.
Priè D, Friedlander G. Genetic disorders of renal phosphate transport. N Engl J Med. 2010;362:2399–409.
Prié D, Huart V, Bakouh N, et al. Nephrolithiasis and osteoporosis associated with hypophosphatemia caused by mutations in the type 2a sodium-phosphate cotransporter. N Engl J Med. 2002;347:983–91.
Sabbagh Y, Jones AO, Tenenhouse HS. PHEXdb, a locus-specific database for mutations causing X-linked hypophosphatemia. Hum Mutat. 2000;16:1–6.
Econs MJ, McEnery PT. Autosomal dominant hypophosphatemic rickets/osteomalacia: clinical characterization of a novel renal phosphate-wasting disorder. J Clin Endocrinol Metab. 1997;82:674–81.
Mayan H, Munter G, Shaharabany M, et al. Hypercalciuria in familial hyperkalemia and hypertension accompanies hyperkalemia and precedes hypertension: description of a large family with the Q565E WNK4 mutation. J Clin Endocrinol Metab. 2004;89:4025–30.
Achard JM, Warnock DG, Disse-Nicodème S, et al. Familial hyperkalemic hypertension: phenotypic analysis in a large family with the WNK1 deletion mutation. Am J Med. 2003;114:495–8.
Jiang Y, Ferguson WB, Peng JB. WNK4 enhances TRPV5-mediated calcium transport: potential role in hypercalciuria of familial hyperkalemic hypertension caused by gene mutation of WNK4. Am J Physiol Renal Physiol. 2007;292:F545–54.
Wolf MT, Zalewski I, Martin FC, et al. Mapping a new suggestive gene locus for autosomal dominant nephrolithiasis to chromosome 9q33.2-q34.2 by total genome search for linkage. Nephrol Dial Transplant. 2005;20:909–14.
Fabris A, Bernich P, Abaterusso C, et al. Bone disease in medullary sponge kidney and effect of potassium citrate treatment. Clin J Am Soc Nephrol. 2009;4:1974–9.
Bruce LJ, Cope DL, Jones GK, et al. Familial distal renal tubular acidosis is associated with mutations in the red cell anion exchanger (Band 3, AE1) gene. J Clin Invest. 1997;100:1693–707.
Wrong O, Bruce LJ, Unwin RJ, et al. Band 3 mutations, distal renal tubular acidosis, and southeast Asian ovalocytosis. Kidney Int. 2002;62:10–9.
Tanphaichitr VS, Sumboonnanonda A, Ideguchi H, et al. Novel AE1 mutations in recessive distal renal tubular acidosis. Loss-of-function is rescued by glycophorin a. J Clin Invest. 1998;102:2173–9.
Karet FE, Finberg KE, Nelson RD, et al. Mutations in the gene encoding B1 subunit of H+-ATPase cause renal tubular acidosis with sensorineural deafness. Nat Genet. 1999;21:84–90.
Smith AN, Skaug J, Choate KA, et al. Mutations in ATP6N1B, encoding a new kidney vacuolar proton pump 116-kD subunit, cause recessive distal renal tubular acidosis with preserved hearing. Nat Genet. 2000;26:71–5.
Gambaro G, Feltrin GP, Lupo A, et al. Medullary sponge kidney (Lenarduzzi-Cacchi-Ricci disease): a Padua Medical School discovery in the 1930s. Kidney Int. 2006;69:663–70.
Cameron S. Medullary sponge kidney. In: Davison AM, Cameron JS, Grunfeld J-P, Ponticelli C, Ritz E, Winearls CG, van Ypersele C, editors. Oxford textbook of clinical nephrology. 3rd ed. Oxford: Oxford University Press; 2004. p. 2495–501.
Kuiper JJ. Medullary sponge kidney in three generations. N Y State J Med. 1971;71:2665–9.
Fabris A, Lupo A, Ferraro PM, et al. The medullary sponge kidney is frequently an inherited disorder: a systematic analysis of a large cohort. In: XLVII ERA-EDTA congress, Munich, 25–28 June 2010.
Torregrossa R, Anglani F, Fabris A, et al. Identification of GDNF gene sequence variations in patients with medullary sponge kidney disease. Clin J Am Soc Nephrol. 2010;5(7):1205–10.
Cochat P, Deloraine A, Rotily M, et al. Epidemiology of primary hyperoxaluria type 1. Nephrol Dial Transplant. 1995;10 Suppl 8:3–7.
Williams HE, Smith Jr LH. Hyperoxaluria in L-glyceric aciduria: possible pathogenic mechanism. Science. 1971;171:390–1.
Monico CG, Weinstein A, Jiang Z, et al. Phenotypic and functional analysis of human SLC26A6 variants in patients with familial hyperoxaluria and calcium oxalate nephrolithiasis. Am J Kidney Dis. 2008;52:1096–103.
Dello Strologo L, Pras E, Pontesilli C, et al. Comparison between SLC3A1 and SLC7A9 cystinuria patients and carriers: a need for a new classification. J Am Soc Nephrol. 2002;13:2547–53.
Botzenhart E, Vester U, Schmidt C, et al. Cystinuria in children: distribution and frequencies of mutations in the SLC3A1 and SLC7A9 genes. Kidney Int. 2002;62:1136–42.
Tanaka M, Itoh K, Matsushita K, et al. Two male siblings with hereditary renal hypouricemia and exercise-induced ARF. Am J Kidney Dis. 2003;42:1287–92.
Ombra MN, Forabosco P, Casula S, et al. Identification of a new candidate locus for uric acid nephrolithiasis. Am J Hum Genet. 2001;68:1119–29.
Carr G, Sayer JA, Simmons NL. Expression and localisation of the pyrophosphate transporter, ANK, in murine kidney cells. Cell Physiol Biochem. 2007;20:507–16.
Jaggi M, Nakagawa Y, Zipperle L, et al. Tamm-Horsfall protein in recurrent calcium kidney stone formers with positive family history: abnormalities in urinary excretion, molecular structure and function. Urol Res. 2007;35:55–62.
Srivastava T, Schwaderer A. Diagnosis and management of hypercalciuria in children. Curr Opin Pediatr. 2009;21:214–9.
Resnick M, Pridgen DB, Goodman HO. Genetic predisposition to formation of calcium oxalate renal calculi. J Am Soc Nephrol. 1997;278:1313–8.
Gambaro G, Marchini F, Piccoli A, et al. The abnormal red-cell oxalate transport is a risk factor for idiopathic calcium nephrolithiasis: a prospective study. J Am Soc Nephrol. 1996;7:608–12.
Trinchieri A. Epidemiology of urolithiasis. Arch Ital Urol Androl. 1996;68:203–49.
Bianchi G, Vezzoli G, Cusi D, et al. Abnormal red-cell calcium pump in patients with idiopathic hypercalciuria. N Engl J Med. 1988;319:897–901.
Ioannidis JP, Ntzani EE, Trikalinos TA, et al. Replication validity of genetic association studies. Nat Genet. 2001;29:306–9.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer-Verlag London
About this chapter
Cite this chapter
Ferraro, P.M., Gambaro, G. (2012). The Genetics of Kidney Stones. In: Talati, J., Tiselius, HG., Albala, D., YE, Z. (eds) Urolithiasis. Springer, London. https://doi.org/10.1007/978-1-4471-4387-1_16
Download citation
DOI: https://doi.org/10.1007/978-1-4471-4387-1_16
Published:
Publisher Name: Springer, London
Print ISBN: 978-1-4471-4383-3
Online ISBN: 978-1-4471-4387-1
eBook Packages: MedicineMedicine (R0)